Ocata Therapeutics Inc (NASDAQ:OCAT)

5.09
Delayed Data
As of Jul 02
 -0.17 / -3.23%
Today’s Change
4.88
Today|||52-Week Range
12.73
-16.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues39.5K39.5K39.5K39.5K
 
 
 
 
 
Cost of Goods Sold15.6K15.6K15.6K15.6K
 
 
 
 
 
Depreciation And Amortization33.4K45.0K63.7K65.1K
 
 
 
 
 
 
Operating ExpensesGross Income-9.5K-21.2K-39.8K-41.3K
 
 
 
 
 
General Expenses4.9M4.0M6.8M7.0M
 
 
 
 
 
Research And Development2.7M2.4M2.9M3.4M
 
 
 
 
 
Total Operating Expenses4.9M4.0M6.9M7.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.9M-4.0M-6.8M-7.0M
 
 
 
 
 
Extraordinary Credit1.4M263.8K25.0K6.0K
 
 
 
 
 
Extraordinary Charge-11.9M0.000.000.00
 
 
Interest Expense On Debt132.5K69.000.000.00
 
 
 
Other Expenses0.000.00-10.9K0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.5M-3.7M-6.8M-7.0M
 
 
 
 
 
Preferred Dividend0.00-672.2K0.000.00
 
 
Net Income-15.5M-3.7M-6.8M-7.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS29.6M33.6M34.6M34.9M
 
 
 
 
 
Shares To Calculate EPS Diluted29.6M33.6M34.6M34.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.00-$0.13-$0.20-$0.20
 
 
 
 
 
EPS Diluted-$1.00-$0.13-$0.20-$0.20
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account